These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23525903)

  • 21. PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions.
    Rudich P; Watkins S; Lamitina T
    PLoS One; 2020; 15(4):e0227464. PubMed ID: 32240172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice.
    Wilburn B; Rudnicki DD; Zhao J; Weitz TM; Cheng Y; Gu X; Greiner E; Park CS; Wang N; Sopher BL; La Spada AR; Osmand A; Margolis RL; Sun YE; Yang XW
    Neuron; 2011 May; 70(3):427-40. PubMed ID: 21555070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
    Sánchez I; Mahlke C; Yuan J
    Nature; 2003 Jan; 421(6921):373-9. PubMed ID: 12540902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy.
    Yu Z; Teng X; Bonini NM
    PLoS Genet; 2011 Mar; 7(3):e1001340. PubMed ID: 21437269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA FISH for detecting expanded repeats in human diseases.
    Urbanek MO; Krzyzosiak WJ
    Methods; 2016 Apr; 98():115-123. PubMed ID: 26615955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference.
    Caplen NJ; Taylor JP; Statham VS; Tanaka F; Fire A; Morgan RA
    Hum Mol Genet; 2002 Jan; 11(2):175-84. PubMed ID: 11809726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling the polyglutamine aggregation pathway in Huntington's disease: from basic studies to clinical applications.
    Sugaya K
    Subcell Biochem; 2012; 65():353-88. PubMed ID: 23225011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triplet repeats in transcripts: structural insights into RNA toxicity.
    Galka-Marciniak P; Urbanek MO; Krzyzosiak WJ
    Biol Chem; 2012 Nov; 393(11):1299-315. PubMed ID: 23052488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.
    Song H; Li H; Guo S; Pan Y; Fu Y; Zhou Z; Li Z; Wen X; Sun X; He B; Gu H; Zhao Q; Wang C; An P; Luo S; Hu Y; Xie X; Lu B
    Brain; 2018 Jun; 141(6):1782-1798. PubMed ID: 29608652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models.
    Hong H; Koon AC; Chen ZS; Wei Y; An Y; Li W; Lau MHY; Lau KF; Ngo JCK; Wong CH; Au-Yeung HY; Zimmerman SC; Chan HYE
    J Biol Chem; 2019 Feb; 294(8):2757-2770. PubMed ID: 30593503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of expanded CAG transcripts triggers nucleolar stress in Huntington's disease.
    Tsoi H; Chan HY
    Cerebellum; 2013 Jun; 12(3):310-2. PubMed ID: 23315009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verification of somatic CAG repeat expansion by pre-PCR fractionation.
    Hunter JM; Crouse AB; Lesort M; Johnson GV; Detloff PJ
    J Neurosci Methods; 2005 May; 144(1):11-7. PubMed ID: 15848234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.
    Pushechnikov A; Lee MM; Childs-Disney JL; Sobczak K; French JM; Thornton CA; Disney MD
    J Am Chem Soc; 2009 Jul; 131(28):9767-79. PubMed ID: 19552411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs).
    Khan E; Tawani A; Mishra SK; Verma AK; Upadhyay A; Kumar M; Sandhir R; Mishra A; Kumar A
    ACS Chem Biol; 2018 Jan; 13(1):180-188. PubMed ID: 29172480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
    Lorincz MT; Zawistowski VA
    Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
    Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
    J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila.
    Iijima-Ando K; Wu P; Drier EA; Iijima K; Yin JC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10261-6. PubMed ID: 16009936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
    Sontag EM; Lotz GP; Agrawal N; Tran A; Aron R; Yang G; Necula M; Lau A; Finkbeiner S; Glabe C; Marsh JL; Muchowski PJ; Thompson LM
    J Neurosci; 2012 Aug; 32(32):11109-19. PubMed ID: 22875942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rab8 Promotes Mutant HTT Aggregation, Reduces Neurodegeneration, and Ameliorates Behavioural Alterations in a Drosophila Model of Huntington's Disease.
    Delfino L; Mason RP; Kyriacou CP; Giorgini F; Rosato E
    J Huntingtons Dis; 2020; 9(3):253-263. PubMed ID: 33044189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.